CitedPeptides

Legal status tracker

By Cited Peptides Editorial Updated Medical review pending

This page has not yet been reviewed by a credentialed medical professional. It is educational and is not medical advice.

Rules change often. Every row shows when it was last verified and links its sources. This is informational, not legal advice.

PeptideUSCanadaEUWADAVerified
BPC-157Not FDA-approved. Status for pharmacy compounding is actively changing: FDA moved it off its "Category 2" (significant safety risk) list in April 2026 and an FDA advisory committee narrowly voted in July 2026 in favour of easing restrictions, but no final FDA decision had been confirmed in the sources checked.Not authorized by Health Canada. Named in a Health Canada public advisory as an unauthorized injectable peptide; "research use only" labels do not make sale for human use legal.No EU marketing authorization from the European Medicines Agency (EMA). Not a lawful medicine or supplement in the EU; national rules on compounding and enforcement vary by country.Prohibited at all times in sport (S0: non-approved substances).
In flux
TB-500Not FDA-approved. Compounding status was under active review in 2026 (an FDA advisory committee narrowly voted in July 2026 to recommend easing restrictions on several peptides including TB-500); confirm the current FDA position before relying on it.Not authorized by Health Canada. Named in a Health Canada public advisory as an unauthorized injectable peptide.No EU marketing authorization from the EMA. Sold online as a research chemical; not a lawful medicine or supplement in the EU.Prohibited at all times in sport (thymosin beta-4 and its derivatives, e.g. TB-500).
In flux
GHK-CuLegal as a cosmetic ingredient in topical products. Injectable GHK-Cu is not an FDA-approved drug; its compounding status was part of FDA's April 2026 changes to the 503A interim list, so verify current rules.Topical cosmetic use is allowed; injectable GHK-Cu is not an authorized drug in Canada.Permitted as a cosmetic ingredient under EU cosmetics rules (check the CosIng database). Injectable GHK-Cu has no EMA authorization.Not listed as a named prohibited substance at the time of verification; check the current WADA Prohibited List.
In flux
SemaglutideFDA-approved prescription drug (Ozempic, Wegovy, Rybelsus). Compounded versions are a separate and contested area; check FDA guidance.Health Canada-authorized prescription drug (Ozempic, Wegovy, Rybelsus).EMA-authorized (centrally authorized as Ozempic, Wegovy and Rybelsus). Prescription-only.Not prohibited in sport.
TirzepatideFDA-approved prescription drug (Mounjaro, Zepbound).Mounjaro is Health Canada-authorized; check Health Canada's Drug Product Database for the weight-management indication and current products.EMA-authorized (centrally authorized as Mounjaro). Prescription-only.Not prohibited in sport.
CJC-1295Not FDA-approved. Verify its compounding status on the FDA 503A bulks list.Not an authorized drug in Canada.No EU marketing authorization from the EMA.Prohibited at all times in sport (growth hormone-releasing factors, S2).
In flux
IpamorelinNot FDA-approved. Compounding status uncertain; verify with the FDA 503A bulks list.Not an authorized drug in Canada.No EU marketing authorization from the EMA.Prohibited at all times in sport (growth hormone secretagogues, S2).
In flux